Kidswell Bio Corporation
Completion of Exercise of Stock Acquisition Rights with Third-Party Allotment ｜ July 2026
Kidswell Bio announced the completion of the exercise of stock acquisition rights with third-party allotment in July 2026, with a total exercised face value of ¥125 million. The monthly exercise ratio is 25%, and the remaining unexercised amount is zero.
Key Figures
- Total Exercised Face Value: 125,000 thousand yen
- Remaining Unexercised Amount: 0 yen
- Shares Distributed: 946,969 shares
AI要約
Overview of Financial Results and Capital Policy
Kidswell Bio announced the completion of the exercise of unsecured convertible bonds with stock acquisition rights with third-party allotment in July 2026. The total exercised face value is ¥125 million, with an exercise ratio reaching 25%, and the unexercised remaining balance is zero. This aims to strengthen capital and improve stock liquidity.
Impact on Shareholders and Future Outlook
With the completion of the exercise of stock acquisition rights with third-party allotment, the dilution of shares is expected to be limited. Going forward, as part of its capital policy, the company will continue financing and shareholder return measures, and promote business expansion and growth strategies. Detailed earnings guidance and next-term plans will be announced separately.
Kidswell Bio Co., Ltd.
Company overview · Stock price · Financial data · All IR
